REQUEST A DEMO
Total
USD $0.00
Search more companies

Neo Pharmachem Company Limited (Thailand)

Main Activities: Pharmacies and Drug Stores
Full name: Neo Pharmachem Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Neo Pharmachem Company Limited is a company in Thailand, with a head office in Bangkok , Special Governed District of. The enterprise currently operates in the Pharmacies and Drug Stores sector. The company was established on May 20, 1991. It currently has a total number of 44 (2024) employees. From the latest financial highlights, Neo Pharmachem Company Limited reported a net sales revenue increase of 8.95% in 2024. During that time, Neo Pharmachem Company Limited’s total assets grew by 7.63%. The net profit margin of Neo Pharmachem Company Limited increased by 5.7% in 2024.

Headquarters
364 Chaloem Prakiat Road
Bangkok , Special Governed District of; Central Thailand; Postal Code: 10250

Contact Details: Purchase the Neo Pharmachem Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Neo Pharmachem Company Limited report to view the information.
Financial Auditors:
Purchase the Neo Pharmachem Company Limited report to view the information.
Incorporation Date:
May 20, 1991
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Neo Pharmachem Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
8.95%
Total Operating Revenue
9.44%
Operating Profit
544.6%
EBITDA
544.6%
Net Profit/Loss for the Period
1033.25%
Total Assets
7.63%
Total Equity
8.35%
Operating Profit Margin
7.4%
Net Profit Margin
5.7%
Return on Equity (ROE)
6.96%
Debt / Equity
-5.01%
Quick Ratio
-0.32%
Cash Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?